Botanical ingredient supplier Natural Remedies has launched Ashwa.30, a novel ashwagandha-based nutraceutical designed to boost energy, enhance endurance and manage stress.
The next-generation functional ingredient is standardised to contain more than 15% withanolides — a key bioactive found within the roots and leaves of ashwagandha that has been touted for adaptogenic benefits.
It also contains 15% of a unique ATP-active fraction, which supports energy production at the cellular level.
Created using Natural Remedies' proprietary Bioactive Optimisation Technology (BOT), the ingredient has been designed to deliver tangible results rapidly at a low dose of 30mg.
“Today’s consumers face constant physical and mental stress, and we saw an opportunity to develop a smarter, more targeted solution,” said Suresh Lakshmikanthan, Natural Remedies' Chief Business Officer.
“By bringing together decades of research on ashwagandha and pairing it with our proprietary extraction processs, Ashwa.30 is efficacious at a much smaller dose," he noted.
Clinical studies performed on Ashwa.30 have found that the nutraceutical can reduce salivary cortisol by nearly 40% within one week — suggesting the ingredient can effectively reduce stress markers in a short period of time.
Ashwa.30 also triggered an eightfold improvement in endurance as measured by VO2 MAX, while preclinical studies suggest that the ingredient can improve physical performance and reduce fatigue by enhancing aerobic energy production over the lactic acid-producing process of anaerobic respiration.
“Ashwa.30 is easy for formulators to use and delivers strong benefits that are backed by science,” said Lakshmikanthan.
“It’s an ideal ingredient for anyone looking to support both mental and physical resilience in today’s high-stress environment," he concluded.